{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T06:17:45Z","timestamp":1766902665156},"reference-count":80,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T00:00:00Z","timestamp":1372377600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0068060","type":"journal-article","created":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T21:15:07Z","timestamp":1372454107000},"page":"e68060","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Rapid and Sensitive Method for Measuring N-Acetylglucosaminidase Activity in Cultured Cells"],"prefix":"10.1371","volume":"8","author":[{"given":"Victor","family":"Mauri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Lotfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Segatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Sardiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,6,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10545-008-0838-5","article-title":"Sanfilippo syndrome: A mini-review","volume":"31","author":"MJ Valstar","year":"2008","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"ref2","first-page":"30","article-title":"Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B. Journal of neuroscience research","volume":"69","author":"HH Li","year":"2002"},{"key":"ref3","first-page":"e772","article-title":"Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B. PloS one","volume":"2","author":"CD Heldermon","year":"2007"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10545-008-1040-5","article-title":"Pathogenic cascades in lysosomal disease-Why so complex?","volume":"32","author":"SU Walkley","year":"2009","journal-title":"Journal of inherited metabolic disease"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2174\/138920111795542651","article-title":"Mucopolysaccharidosis type III (Sanfilippo Syndrome): emerging treatment strategies","volume":"12","author":"J de Ruijter","year":"2011","journal-title":"Current pharmaceutical biotechnology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"JE Wraith","year":"2008","journal-title":"European journal of pediatrics"},{"key":"ref7","first-page":"182","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I. The New England journal of medicine","volume":"344","author":"ED Kakkis","year":"2001"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)","volume":"144","author":"P Harmatz","year":"2004","journal-title":"The Journal of pediatrics"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ymgme.2009.10.002","article-title":"Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimen","volume":"99","author":"D Auclair","year":"2010","journal-title":"Molecular genetics and metabolism"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/ajmg.a.32294","article-title":"Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression","volume":"146A","author":"MV Munoz-Rojas","year":"2008","journal-title":"American journal of medical genetics Part A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1073\/pnas.1214779109","article-title":"Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII","volume":"109","author":"HT Huynh","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1651-2227.2008.00656.x","article-title":"Substrate reduction therapy","volume":"97","author":"FM Platt","year":"2008","journal-title":"Acta paediatrica"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF03195237","article-title":"Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases","volume":"48","author":"J Jakobkiewicz-Banecka","year":"2007","journal-title":"Journal of applied genetics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jmb.2004.03.012","article-title":"alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients","volume":"338","author":"LK Hein","year":"2004","journal-title":"Journal of molecular biology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tig.2008.08.010","article-title":"Introducing sense into nonsense in treatments of human genetic diseases","volume":"24","author":"L Linde","year":"2008","journal-title":"Trends in genetics : TIG"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"v49","DOI":"10.1093\/rheumatology\/ker396","article-title":"Therapy for the mucopolysaccharidoses","volume":"50","author":"V Valayannopoulos","year":"2011","journal-title":"Rheumatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/mthe.2001.0514","article-title":"Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery","volume":"5","author":"H Fu","year":"2002","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/mt.2010.265","article-title":"Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes","volume":"19","author":"NM Ellinwood","year":"2011","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1523\/JNEUROSCI.3558-04.2004","article-title":"Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum","volume":"24","author":"A Cressant","year":"2004","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1174447","article-title":"A gene network regulating lysosomal biogenesis and function","volume":"325","author":"M Sardiello","year":"2009","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.4161\/cc.8.24.10263","article-title":"Lysosomal enhancement: a CLEAR answer to cellular degradative needs","volume":"8","author":"M Sardiello","year":"2009","journal-title":"Cell cycle"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tins.2011.05.006","article-title":"Clarifying lysosomal storage diseases","volume":"34","author":"ML Schultz","year":"2011","journal-title":"Trends in neurosciences"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.devcel.2011.07.016","article-title":"Transcriptional activation of lysosomal exocytosis promotes cellular clearance","volume":"21","author":"DL Medina","year":"2011","journal-title":"Developmental cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"142ra197","DOI":"10.1126\/scitranslmed.3003799","article-title":"PGC-1alpha rescues Huntington\u2019s disease proteotoxicity by preventing oxidative stress and promoting TFEB function","volume":"4","author":"T Tsunemi","year":"2012","journal-title":"Science translational medicine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1128\/MCB.00930-12","article-title":"Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-beta precursor protein","volume":"32","author":"C Parr","year":"2012","journal-title":"Molecular and cellular biology"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Song W, Wang F, Savini M, Ake A, di Ronza A, <etal>et al<\/etal>.. (2013) TFEB regulates lysosomal proteostasis. Human molecular genetics.","DOI":"10.1093\/hmg\/ddt052"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson\u2019s disease","volume":"30","author":"B Dehay","year":"2010","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10545-005-0093-y","article-title":"Molecular defects in Sanfilippo syndrome type B (mucopolysaccharidosis IIIB)","volume":"28","author":"CE Beesley","year":"2005","journal-title":"Journal of inherited metabolic disease"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.0009-9163.2004.00210.x","article-title":"Sanfilippo B syndrome: molecular defects in Greek patients","volume":"65","author":"C Beesley","year":"2004","journal-title":"Clinical genetics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s004390000429","article-title":"Molecular defects in the alpha-N-acetylglucosaminidase gene in Italian Sanfilippo type B patients","volume":"107","author":"A Tessitore","year":"2000","journal-title":"Human genetics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajmg.a.33779","article-title":"Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece","volume":"155A","author":"B Heron","year":"2011","journal-title":"American journal of medical genetics Part A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.bi.60.070191.001353","article-title":"Lysosomal storage diseases","volume":"60","author":"EF Neufeld","year":"1991","journal-title":"Annual review of biochemistry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0925-4439(94)00075-2","article-title":"Lysosomal storage diseases","volume":"1270","author":"V Gieselmann","year":"1995","journal-title":"Biochimica et biophysica acta"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/hmg\/9.6.967","article-title":"Structural features of normal and mutant human lysosomal glycoside hydrolases deduced from bioinformatics analysis","volume":"9","author":"P Durand","year":"2000","journal-title":"Human molecular genetics"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrm1052","article-title":"Quality control in the endoplasmic reticulum","volume":"4","author":"L Ellgaard","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"43454","DOI":"10.1074\/jbc.M111.274332","article-title":"Inhibition of endoplasmic reticulum-associated degradation rescues native folding in loss of function protein misfolding diseases","volume":"286","author":"F Wang","year":"2011","journal-title":"The Journal of biological chemistry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/emmm.200900036","article-title":"Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics","volume":"1","author":"G Parenti","year":"2009","journal-title":"EMBO molecular medicine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"AR Sawkar","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2008.06.037","article-title":"Chemical and biological approaches synergize to ameliorate protein-folding diseases","volume":"134","author":"TW Mu","year":"2008","journal-title":"Cell"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/adt.2011.0370","article-title":"Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders","volume":"9","author":"KJ Valenzano","year":"2011","journal-title":"Assay and drug development technologies"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1111\/j.1742-4658.2007.06041.x","article-title":"Active-site-specific chaperone therapy for Fabry disease. Yin and Yang of enzyme inhibitors","volume":"274","author":"JQ Fan","year":"2007","journal-title":"FEBS J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1074\/jbc.M609304200","article-title":"Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis","volume":"282","author":"GH Maegawa","year":"2007","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"GH Maegawa","year":"2009","journal-title":"J Biol Chem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.chembiol.2006.12.006","article-title":"High-throughput screening for human lysosomal beta-N-Acetyl hexosaminidase inhibitors acting as pharmacological chaperones","volume":"14","author":"MB Tropak","year":"2007","journal-title":"Chem Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"13192","DOI":"10.1073\/pnas.0705637104","article-title":"Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease","volume":"104","author":"W Zheng","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/138620708786734244","article-title":"Optimization and validation of two miniaturized glucocerebrosidase enzyme assays for high throughput screening","volume":"11","author":"DJ Urban","year":"2008","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1073\/pnas.69.7.1720","article-title":"Sanfilippo syndrome: profound deficiency of alpha-acetylglucosaminidase activity in organs and skin fibroblasts from type-B patients","volume":"69","author":"JS O\u2019Brien","year":"1972","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0008-6215(00)84698-4","article-title":"4-Methylumbelliferyl 2-acetamido-2-deoxy-alpha-D-glucopyranoside, a fluorogenic substrate for N-acetyl-alpha-D-glucosaminidase","volume":"96","author":"P Chow","year":"1981","journal-title":"Carbohydrate research"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1399-0004.1985.tb00217.x","article-title":"4-Methylumbelliferyl alpha-N-acetylglucosaminidase activity for diagnosis of Sanfilippo B disease","volume":"27","author":"J Marsh","year":"1985","journal-title":"Clinical genetics"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1021\/bc010007l","article-title":"Design and synthesis of substrate and internal standard conjugates for profiling enzyme activity in the Sanfilippo syndrome by affinity chromatography\/electrospray ionization mass spectrometry","volume":"12","author":"SA Gerber","year":"2001","journal-title":"Bioconjugate chemistry"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/ac0100650","article-title":"Direct profiling of multiple enzyme activities in human cell lysates by affinity chromatography\/electrospray ionization mass spectrometry: application to clinical enzymology","volume":"73","author":"SA Gerber","year":"2001","journal-title":"Analytical chemistry"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1021\/bc200609x","article-title":"New substrates and enzyme assays for the detection of mucopolysaccharidosis III (Sanfilippo Syndrome) types A, B, C, and D by tandem mass spectrometry","volume":"23","author":"BJ Wolfe","year":"2012","journal-title":"Bioconjugate chemistry"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0009-8981(82)90079-1","article-title":"Detection of the Sanfilippo type B syndrome using radiolabelled oligosaccharides as substrates for the estimation of alpha-N-acetylglucosaminidase","volume":"120","author":"JJ Hopwood","year":"1982","journal-title":"Clin Chim Acta"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays","volume":"4","author":"JH Zhang","year":"1999","journal-title":"Journal of biomolecular screening"},{"key":"ref55","first-page":"55","article-title":"Ganglioside GM2 storage diseases: hexosaminidase deficiencies in cultured fibroblasts","volume":"23","author":"S Okada","year":"1971","journal-title":"American journal of human genetics"},{"key":"ref56","first-page":"64","article-title":"NAGLU mutations underlying Sanfilippo syndrome type B. American journal of human genetics","volume":"62","author":"A Schmidtchen","year":"1998"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1136\/jmg.39.2.e3","article-title":"Identification and characterisation of mutations underlying Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB)","volume":"39","author":"GJ Lee-Chen","year":"2002","journal-title":"Journal of medical genetics"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/jmg.35.11.910","article-title":"Identification of 12 novel mutations in the alpha-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB)","volume":"35","author":"CE Beesley","year":"1998","journal-title":"Journal of medical genetics"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01805711","article-title":"Diagnosis of the mucopolysaccharidoses using cultured skin fibroblasts and amniotic fluid cells","volume":"1","author":"J Butterworth","year":"1978","journal-title":"Journal of inherited metabolic disease"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","article-title":"Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways","volume":"20","author":"M Palmieri","year":"2011","journal-title":"Human molecular genetics"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.molmed.2006.06.001","article-title":"Stop-codon read-through for patients affected by a lysosomal storage disorder","volume":"12","author":"DA Brooks","year":"2006","journal-title":"Trends in molecular medicine"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ymgme.2011.05.021","article-title":"Stop codon read-through with PTC124 induces palmitoyl-protein thioesterase-1 activity, reduces thioester load and suppresses apoptosis in cultured cells from INCL patients","volume":"104","author":"C Sarkar","year":"2011","journal-title":"Molecular genetics and metabolism"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"JQ Fan","year":"1999","journal-title":"Nat Med"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis","volume":"100","author":"J Matsuda","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2006.09.010","article-title":"Chemical chaperones improve transport and enhance stability of mutant alpha-glucosidases in glycogen storage disease type II","volume":"90","author":"T Okumiya","year":"2007","journal-title":"Mol Genet Metab"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.mt.6300074","article-title":"Pharmacological enhancement of mutated alpha-glucosidase activity in fibroblasts from patients with Pompe disease","volume":"15","author":"G Parenti","year":"2007","journal-title":"Mol Ther"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"13478","DOI":"10.1074\/jbc.M308523200","article-title":"Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients","volume":"279","author":"MB Tropak","year":"2004","journal-title":"J Biol Chem"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1111\/j.1742-4658.2007.06042.x","article-title":"Pharmacologic chaperoning as a strategy to treat Gaucher disease","volume":"274","author":"Z Yu","year":"2007","journal-title":"FEBS J"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1073\/pnas.0711491105","article-title":"Structural and mechanistic insight into the basis of mucopolysaccharidosis IIIB","volume":"105","author":"E Ficko-Blean","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"21200","DOI":"10.1073\/pnas.1119181109","article-title":"Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease","volume":"108","author":"J Lu","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/cb100321m","article-title":"Ca2+ homeostasis modulation enhances the amenability of L444P glucosylcerebrosidase to proteostasis regulation in patient-derived fibroblasts","volume":"6","author":"F Wang","year":"2011","journal-title":"ACS chemical biology"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.chembiol.2011.04.008","article-title":"Lacidipine remodels protein folding and Ca 2+ homeostasis in Gaucher\u2019s disease fibroblasts: a mechanism to rescue mutant glucocerebrosidase","volume":"18","author":"F Wang","year":"2011","journal-title":"Chemistry & biology"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ncomms1735","article-title":"Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release","volume":"3","author":"D Shen","year":"2012","journal-title":"Nature communications"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1093\/hmg\/dds145","article-title":"Ryanodine receptor antagonists adapt NPC1 proteostasis to ameliorate lipid storage in Niemann-Pick type C disease fibroblasts","volume":"21","author":"T Yu","year":"2012","journal-title":"Human molecular genetics"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1042\/BST0381465","article-title":"Treatments for lysosomal storage disorders","volume":"38","author":"R Lachmann","year":"2010","journal-title":"Biochemical Society transactions"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/iub.284","article-title":"Therapy for lysosomal storage disorders","volume":"62","author":"M Beck","year":"2010","journal-title":"IUBMB life"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/mt.2009.53","article-title":"The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts","volume":"17","author":"C Porto","year":"2009","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10545-011-9424-3","article-title":"Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and the human recombinant alpha-galactosidase A in cultured fibroblasts from patients with Fabry disease","volume":"35","author":"C Porto","year":"2012","journal-title":"Journal of inherited metabolic disease"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"AH Futerman","year":"2004","journal-title":"Nature reviews Molecular cell biology"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ymthe.2006.01.006","article-title":"Gene therapy for lysosomal storage diseases","volume":"13","author":"MS Sands","year":"2006","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0068060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T08:42:21Z","timestamp":1715589741000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0068060"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Dardis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,28]]},"references-count":80,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0068060","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,28]]}}}